IF YOU PRESCRIBE SUBSCRIBE

If you’re a health professional, subscribe to receive regular email updates from Australian Prescriber

Subscribe
Letters to the Editor

Oral complications of cytotoxic therapy

C.L. Reynolds, A. Bonaventura
  • 1 April 1996
Editorial

Calcium antagonists: the current controversy

Robert F.W. Moulds
  • 1 April 1996
Article

Acute myocardial infarction: early treatment

Philip Aylward
  • 1 April 1996
Letters to the Editor

The eye of Horus

Peter J. Mack
  • 1 April 1996
Feature

From the journals

John Marley
  • 1 April 1996
Experimental and Clinical Pharmacology

Corticosteroids - mechanisms of action

John W. Funder
  • 1 April 1996
Article

Treatment of common lower respiratory tract infections

Keryn Christiansen
  • 1 April 1996
Article

Drug utilisation

  • 1 April 1996
Feature

Your questions to the PBAC

Paul O'Brien
  • 1 April 1996
Letters to the Editor

The new antidepressants

P.K. Gillman, G. Shenfield, J.W.G. Tiller
  • 1 April 1996
Letters to the Editor

Cytotoxic therapy

A.O. Langlands
  • 1 April 1996
Article

Drug interactions

Prepared by J.R. Stockigt
  • 1 April 1996
Letters to the Editor

Treatment of attention deficit hyperactivity disorder

Karl R. Wood, P. Hazell
  • 1 April 1996
NEW DRUGS
Perhexiline maleate
  • 1 April 1996
Sevoflurane
  • 1 April 1996
Desmopressin acetate
  • 1 April 1996
Sumatriptan
  • 1 April 1996
Calcitriol
  • 1 April 1996
Ketoprofen
  • 1 April 1996
Mivacurium chloride
  • 1 April 1996
Ganciclovir
  • 1 April 1996
Baclofen
  • 1 April 1996
Hepatitis A vaccine
  • 1 April 1996
Docetaxel
  • 1 April 1996
Zuclopenthixol acetate
  • 1 April 1996
Tretinoin
  • 1 April 1996

IF YOU PRESCRIBE SUBSCRIBE

If you’re a health professional, subscribe to receive regular email updates from Australian Prescriber

Subscribe